Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Vaccine-maker Medicago invests $245-million for building production complex in Quebec

Wednesday, May 20, 2015

Vaccinemaker Medicago says its building a million production complex in Quebec City where it already has its head office and laboratories The company says it has received financial support from all three levels of government including a million lo...

Achillion Pharmaceuticals partners with Johnson & Johnson to develop hepatitis C drugs

Wednesday, May 20, 2015

Achillion Pharmaceuticals Inc said it will collaborate with Johnson Johnson to develop and market its hepatitis C drugs including an oral regimen that could work on all genotypes and shorten treatment time Achillion will be eligible for milestone p...

China's Livzon Pharma to form JV with US biotech firm Cynvenio in China

Wednesday, May 20, 2015

Says signs agreement to invest million to subscribe to US firm Cynvenios series B preferred stock Says signs framework agreement with Cynvenio to firm a JV in China with registered capital million yuan million reuterscom

Biotech group Ablynx to raise 100 mln euros from convertible bonds for research pipeline

Wednesday, May 20, 2015

Belgian biotech Ablynx on Wednesday said it would raise million euros million through an issue of convertible bonds to fund its research pipeline and further tests of its experimental drugs Ablynx said the bonds would have an annual coupon of betw...

Amgen cholesterol drug could get EU green light this week

Wednesday, May 20, 2015

Amgens new cholesterol drug Repatha could be recommended for approval in Europe as early as this week putting it ahead in a race with a rival product from Sanofi Amgens new cholesterol drug Repatha could be recommended for approval in Europe as earl...

U.S. FDA approves longer-acting version of J&J's schizophrenia drug, Invega Trinza

Wednesday, May 20, 2015

The US Food and Drug Administration approved a longeracting version of Johnson Johnsons schizophrenia treatment developed by the companys Janssen Pharmaceuticals unit The FDA approved the drug Invega Trinza to be administered just four times a year...

Lannett Company to acquire Privately Held Silarx Pharma

Tuesday, May 19, 2015

Lannett Company Inc said it has signed a definitive agreement to acquire privately held Silarx Pharmaceuticals Inc and a related real estate entity a manufacturer and marketer of liquid generic pharmaceutical products The transaction is expected to...

AstraZeneca to invest $285 million in Swedish biotech drug factory

Tuesday, May 19, 2015

AstraZeneca is investing million to expand biotech drug manufacturing in Sweden as the company bets on the future of hightech medicine for future growth The new facility for biological medicines in Sodertalje will supply medicines for clinical tria...

Moberg Pharma's partner Menarini Asia-Pacific launches Kerasal Nail in China

Tuesday, May 19, 2015

Moberg Pharmas partner launches Kerasal Nail in China Sees Moberg Pharmas distribution agreement with Menarini Group a top global pharmaceutical company includes Italy China and eight countries in Southeast Asia Preparations are ongoing in ot...

Boehringer Ingelheim buys Pharmaxis' Phase 1 Anti-inflammatory Drug Candidate

Monday, May 18, 2015

Boehringer Ingelheim and pharmaceutical company Pharmaxis announced that Boehringer Ingelheim has exercised its option and acquired the investigational drug PXSA to develop it for the treatment of the liverrelated condition NASH and to prevent its co...